This inventor holds 3 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Fujifilm Corporation. Active years: 2022-2026.
Location History:
- Kanagawa, JP (2022)
- Ashigara-kami-gun, JP (2023)
Company Filing History:
Years Active: 2022-2026
Title: Haruki Tomikawa: Innovator in Biocompatible Materials
Introduction
Haruki Tomikawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of biocompatible materials, holding 3 patents that showcase his innovative approach to material science.
Latest Patents
One of his latest patents is focused on a biocompatible material that is capable of forming a gel with excellent retention and scratch resistance. This biocompatible material includes an alginate with a weight-average molecular weight of 1 million or more, an aluminum compound, a carboxyvinyl polymer, and an oil-based base material. Notably, this material is substantially free of water, which enhances its applicability in various medical and technological fields. Another significant patent involves a medium evaluation method, which assesses the suitability of a medium for culturing cell aggregates in a suspended state. This method includes dispersing particles in a medium, measuring their sedimentation velocity, and using this velocity as an index to determine the medium's adequacy for cell retention and recovery efficiency.
Career Highlights
Haruki Tomikawa is currently employed at Fujifilm Corporation, where he continues to develop innovative solutions in material science. His work has been instrumental in advancing the capabilities of biocompatible materials, which are crucial for medical applications.
Collaborations
He collaborates with talented coworkers, including Koji Takaku and Kosuke Chiba, who contribute to his research and development efforts.
Conclusion
Haruki Tomikawa's contributions to biocompatible materials and his innovative patents reflect his dedication to advancing technology in the medical field. His work at Fujifilm Corporation positions him as a key player in the ongoing development of materials that enhance cell culture and retention.